Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
19.17
+0.30 (1.59%)
Jun 8, 2026, 11:20 AM EDT - Market open
Aktis Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 371.63 | 37.78 | 37.16 | 29.51 | 128.6 |
Short-Term Investments | 166.85 | 189 | 260.01 | 68.35 | - |
Cash & Short-Term Investments | 538.48 | 226.79 | 297.17 | 97.86 | 128.6 |
Cash Growth | 72.36% | -23.68% | 203.66% | -23.90% | - |
Other Current Assets | 5.46 | 3.52 | 3.69 | 2.34 | 3.88 |
Total Current Assets | 543.94 | 230.31 | 300.85 | 100.2 | 132.48 |
Net Property, Plant & Equipment | 28.11 | 27.25 | 20.87 | 20.92 | 4.87 |
Other Long-Term Assets | 4.75 | 7.33 | 4.46 | 1.23 | 0.98 |
Total Assets | 576.8 | 264.89 | 326.18 | 122.36 | 138.32 |
Accounts Payable | 1.23 | 1.74 | 1.92 | 0.96 | 0.49 |
Accrued Expenses | 6.3 | 9.52 | 6.33 | 3.75 | 3.93 |
Current Portion of Leases | 1.43 | 1.32 | 1.3 | 1.53 | 0.85 |
Unearned Revenue | 18.96 | 18.66 | 9.28 | - | - |
Total Current Liabilities | 27.91 | 31.24 | 18.82 | 6.24 | 5.28 |
Long-Term Leases | 10.15 | 10.23 | 10.71 | 11.87 | 0.92 |
Other Long-Term Liabilities | 32.63 | 36.16 | 51.04 | 0.5 | 1.31 |
Total Long-Term Liabilities | 42.78 | 46.39 | 61.75 | 12.37 | 2.23 |
Total Liabilities | 70.69 | 77.63 | 80.58 | 18.61 | 7.5 |
Common Stock | 0.01 | - | - | - | - |
Additional Paid-in Capital | 681.23 | 10.37 | 4.91 | 2.47 | 0.98 |
Accumulated Other Comprehensive Income | -0.24 | 0.04 | 0.12 | 0.08 | - |
Retained Earnings | -174.89 | -156.56 | -92.83 | -48.85 | -20.21 |
Total Common Shareholders' Equity | 506.11 | -146.15 | -87.8 | -46.31 | -19.23 |
Minority Interest | - | 333.41 | 333.41 | 150.05 | 150.05 |
Shareholders' Equity | 506.11 | 187.26 | 245.61 | 103.74 | 130.82 |
Total Liabilities & Equity | 576.8 | 264.89 | 326.18 | 122.36 | 138.32 |
Total Debt | 11.58 | 11.55 | 12.01 | 13.4 | 1.78 |
Net Cash (Debt) | 526.91 | 215.24 | 285.16 | 84.46 | 126.82 |
Net Cash Growth | 144.80% | -24.52% | 237.63% | -33.40% | - |
Net Cash Per Share | 9.53 | 264.58 | 404.96 | 137.29 | 245.11 |
Book Value | 506.11 | -146.15 | -87.8 | -46.31 | -19.23 |
Book Value Per Share | 9.16 | -179.65 | -124.69 | -75.27 | -37.17 |
Tangible Book Value | 506.11 | -146.15 | -87.8 | -46.31 | -19.23 |
Tangible Book Value Per Share | 9.16 | -179.65 | -124.69 | -75.27 | -37.17 |